0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.74%
Revenue growth under 50% of 0819.HK's 40.44%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
44.00%
Gross profit growth at 50-75% of 0819.HK's 68.14%. Martin Whitman would question if cost structure or brand is lagging.
175.08%
EBIT growth 1.25-1.5x 0819.HK's 130.67%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
175.08%
Operating income growth 1.25-1.5x 0819.HK's 130.67%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
228.07%
Net income growth above 1.5x 0819.HK's 36.44%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
228.28%
EPS growth above 1.5x 0819.HK's 37.88%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
228.28%
Diluted EPS growth above 1.5x 0819.HK's 36.36%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.00%
Slight or no buybacks while 0819.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.00%
Reduced diluted shares while 0819.HK is at 0.03%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-99.98%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-63.53%
Negative OCF growth while 0819.HK is at 539.86%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.45%
Negative FCF growth while 0819.HK is at 128.80%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-51.09%
Negative 10Y revenue/share CAGR while 0819.HK stands at 746.19%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.87%
5Y revenue/share CAGR under 50% of 0819.HK's 185.13%. Michael Burry would suspect a significant competitive gap or product weakness.
-51.44%
Negative 3Y CAGR while 0819.HK stands at 109.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2256.08%
Negative 10Y OCF/share CAGR while 0819.HK stands at 2394.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2477.32%
Negative 5Y OCF/share CAGR while 0819.HK is at 33.73%. Joel Greenblatt would question the firm’s operational model or cost structure.
5.55%
3Y OCF/share CAGR under 50% of 0819.HK's 121.81%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-9.39%
Negative 10Y net income/share CAGR while 0819.HK is at 180.01%. Joel Greenblatt sees a major red flag in long-term profit erosion.
37.21%
5Y net income/share CAGR at 75-90% of 0819.HK's 42.62%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
153.00%
Positive short-term CAGR while 0819.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
65.53%
Below 50% of 0819.HK's 354.25%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
71.18%
Below 50% of 0819.HK's 201.12%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-9.27%
Negative 3Y equity/share growth while 0819.HK is at 116.41%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-99.92%
Cut dividends over 10 years while 0819.HK stands at 190.27%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-99.99%
Negative near-term dividend growth while 0819.HK invests at 149.13%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.71%
AR growth is negative/stable vs. 0819.HK's 30.97%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-1.97%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.97%
Negative asset growth while 0819.HK invests at 1.27%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.25%
50-75% of 0819.HK's 8.56%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-16.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-32.73%
Our R&D shrinks while 0819.HK invests at 28.84%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.50%
We cut SG&A while 0819.HK invests at 57.90%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.